|
|
CombinatoRx is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs.
245 First Street, East Cambridge
Requirement: |
- Find corporate headquarters and research & development space for biopharmaceutical firm that is experiencing rapid growth.
- Meet company’s desire to stay in close proximity to their R&D laboratory and to not pay laboratory rents for office space.
- New site needed to provide potential expansion space.
|
| Solution: |
- RBJ conducted an extensive search for space in the Boston and Cambridge markets.
- Worked with CombinatoRx executives to identify the ideal preferences for the new space.
- Targeted mixed-use projects that could offer both office space for corporate executives and laboratory space for R&D component.
|
| Result: |
- RBJ quickly identified several locations, narrowing the search based on parameters cited by CominatorRx.
- Identified 245 First Street/Cambridge Science Center as preferred choice.
- Secured 18,000 square feet of office space in office tower and 24,000 square feet in laboratory building.
- CombinatorRx successfully went public in Q1 2006 and expanded into an additional 23,000 square feet in a laboratory building.
|
| |
|
|
